Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$4,859,715
+$110,491 QoQ
Shares Held
19,135
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#1,635
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Resonant Capital Advisors, LLC holds $36,919,957 across 13 Drug Manufacturers - General names. JNJ ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,392 | $7,666,757 | |
| 2 | AMGN |
Amgen Inc
|
15,803 | $5,722,582 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
19,135 | $4,859,715 | |
| 4 | ABBV |
AbbVie Inc.
|
16,399 | $4,126,644 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,697 | $4,073,064 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,095 | $3,802,202 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
49,118 | $2,830,179 | |
| 8 | PFE |
Pfizer Inc
|
52,773 | $1,270,773 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,859,715 | 19,135 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $4,749,224 | 19,429 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $6,811,138 | 32,912 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $5,867,986 | 31,647 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $4,576,542 | 29,961 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,751,813 | 28,653 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $3,801,625 | 26,287 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $4,202,377 | 25,931 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $3,683,670 | 25,203 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,163,244 | 26,318 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $3,918,343 | 24,999 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $4,172,231 | 26,788 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $4,088,012 | 24,698 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,497,420 | 22,564 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $4,304,783 | 24,369 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $3,789,625 | 23,198 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $4,023,441 | 22,666 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $3,985,725 | 22,489 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $3,575,191 | 20,899 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,850,152 | 17,648 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $2,589,218 | 15,717 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $2,527,374 | 15,378 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,224,723 | 14,136 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $2,011,368 | 13,510 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,963,054 | 13,959 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,382,500 | 18,169 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||